A major trial demonstrated the glucose-lowering drug empagliflozin reduces cardiovascular morbidity and mortality in individuals with Type 2 diabetes and existing cardiovascular disease. Clinicians and researchers discuss how it does so and who is most likely to benefit.
Results of a phase 1b clinical trial published in Nature reveal scientists may be one step closer to finding a treatment that safely impedes the biological progression of Alzheimer’s disease.
Improving symptoms of depression in lung cancer patients is associated with longer survival, according to a recent study. The findings highlight the need for oncology physicians to address mental health issues their patients may be facing, experts say.
Recent research demonstrates the chief mechanism by which smoking damages sperm.
Androgen deprivation therapy (ADT) is a staple of treatment for prostate cancer, but a recent study adds to a growing body of evidence that it places men at higher risk of cognitive decline.
Recent research finds that regardless of the drug selected, physicians should exercise caution when prescribing antipsychotics to Alzheimer’s patients.
Osteoporosis leads to a broken bone for approximately half of Caucasian and Asian women older than age 50 in the United States, though bone mass loss begins decades earlier.
Two studies at Purdue University found supplementation with soluble corn fiber...
A review of studies by researchers in the United Kingdom and Australia finds patterns of improvement in physical activity and ability 12 months after bariatric surgery.
Researchers assessing the role that venom plays in activating nerve fibers involved in pain sensation have uncovered a surprising mechanism that may influence irritable bowel syndrome (IBS)-related pain.
Not all plant-based foods provide equal benefit in terms of reducing risk of diabetes, a new Harvard study finds.
- 1 of 4
- next ›